2-(6,7-dimethoxyquinazolin-4-yl)-5-(pyridin-2-yl)-2H-1,2,4-triazol-3-amine
CAS : 1080622-86-1
Ref. 3D-FD43368
25mg | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
2-(6,7-Dimethoxyquinazolin-4-yl)-5-(pyridin-2-yl)-2H-1,2,4-triazol-3-amine is an inhibitor drug that is used in the treatment of cancer. It inhibits the growth of cancer cells by binding to their DNA and inhibiting protein synthesis. This drug has been shown to inhibit angiogenesis by reducing the production of VEGF and other proangiogenic factors. 2-(6,7-Dimethoxyquinazolin-4-yl)-5-(pyridin-2-yl)-2H-1,2,4-triazol-3-amine also reduces the production of oncogenes such as cSrc and Akt. It binds to the active site on epidermal growth factor receptor (EGFR) kinase domain that is involved in cell proliferation and survival. The binding causes a conformational change in